《大行報告》大摩微升甲骨文(ORCL.US)目標價至106美元 評級「與大市同步」
摩根士丹利輕微上調甲骨文(ORCL.US)目標價,由105美元上調至106美元,評級「與大市同步」。
大摩指,甲骨文除收入遜預期,Fusion業務增長下滑、雲基建(OCI)不及市場高預期及資本開支按年跌24%,或令市場質疑生成人工智能需求轉化為收益的時間,以及更廣泛業務增長的持久性,並拖累公司業務動力。
報告提出,投資者對公司與Nvidia(NVDA.US)緊密閞係及公司取得圖像處理器供應能力表現振奮,但資本開支遠低於市場預期且按年下滑,則令很多人感到意外。縱使去年有建立庫存因素,且數據中心容量需時建立,但資本開支下降或令人質疑人工智能晶片需求與公司的雲基建增長是否有緊密關係。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.